Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
NCT00731302
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
aspirin and meloxicam
Sponsor
Vanderbilt University
Collaborators
[object Object]